Daurismo (Glasdegib)

Daurismo (glasdegib) is an oral medication used to treat certain types of cancer. This prescription drug works by targeting specific proteins to help manage disease progression.

Daurismo is primarily used in the treatment of acute myeloid leukemia (AML) in adults who are not candidates for standard chemotherapy. The medication targets hedgehog signaling pathways, which play a role in cancer cell growth. Patients often wonder, 'What is Daurismo used for?' It is specifically designed for oral use and is prescribed based on individual medical needs.

Common effects of Daurismo may include fatigue, muscle pain, and nausea. Some users also report changes in taste or appetite. These effects can vary widely depending on the individual and their specific treatment plan.

Daurismo should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Pregnant women or those planning to become pregnant should discuss the risks with their doctor.

Daurismo may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect how Daurismo works in the body.